STS launches their fourth mobile application developed for the FDA

STS launches their fourth mobile application developed for the FDA

FDA launches mobile app to increase access to information about drugs

STS designed and developed the Drugs@FDA Express mobile application for the U.S. Food and Drug Administration. On this mobile app, the public can search for information about FDA-approved brand and generic prescription and over-the-counter human drugs and biological therapeutic products. The FDA currently operates the Drugs@FDA webpage, which includes information about drug products approved by the agency, including patient information, drug labeling, approval letters, reviews and other information. The Drugs@FDA Express mobile app is a streamlined version of Drugs@FDA, allowing users to search on their mobile devices for certain product information based on product name, active ingredient or application number using a single search box. Some information (like labeling supplements and approval letters) won’t be available on the app, but can be found on the Drugs@FDA webpage.

The app will also feature the most recent product approvals, within seven days, links to the Drugs@FDA glossary and frequently asked questions. It will also provide contact information for the FDA’s Division of Drug Information, druginfo@fda.hhs.gov.

This free mobile app can be downloaded via iTunes (for Apple devices) and the Google Play store (for Android devices).